Bone health boost may help pregnant women with epilepsy

NCT ID NCT07651709

First seen Jun 18, 2026 · Last updated Jun 19, 2026 · Updated 1 time

Summary

This study tests whether giving calcium and vitamin D supplements based on vitamin D levels can improve pregnancy outcomes in women with epilepsy. Researchers will enroll 80 women who are planning pregnancy or are in early pregnancy. Participants will receive different doses of calcium and vitamin D depending on their initial vitamin D levels, and the study will track bone health markers in both mothers and babies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Fourth Affiliated Hospital of Zhejiang University School of Medicine

    RECRUITING

    Zhejiang, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

calcium and vitamin D supplements

What this could lead to

If successful, this could establish a simple, evidence-based vitamin D supplementation strategy to improve bone health and pregnancy outcomes in women with epilepsy.

What could go wrong

This is a small, early-stage trial with only 80 participants, so results may not apply widely. The study focuses on bone metabolism markers rather than major clinical outcomes, so the real-world benefit is uncertain.

Conditions

The condition(s) this trial relates to.

epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.